Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 26, 2026, 3:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Urinary Stress Incontinence Clear all
Completed Not applicable Interventional

Pelvital Stress Urinary Incontinence Training Device: P-SUIT

NCT02954042
View directory record Official record
Conditions
Incontinence
Interventions
Pelvital probe, Placebo Probe
Device
Lead sponsor
Pelvital USA, Inc.
Industry
Eligibility
18 Years to 75 Years · Female only
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2019
U.S. locations
4
States / cities
Maple Grove, Minnesota • Maplewood, Minnesota • Minneapolis, Minnesota + 1 more
Source: ClinicalTrials.gov public record
Updated Apr 13, 2021 · Synced Sep 26, 2026, 3:03 AM EDT
Recruiting No phase listed Observational

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

NCT04829357
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
Intervention
Device
Lead sponsor
Ethicon, Inc.
Industry
Eligibility
21 Years and older · Female only
Enrollment
195 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2038
U.S. locations
1
States / cities
North Wales, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jul 5, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Effects of Neuromuscular Pelvic Realigning Exercises on Pelvic Floor Muscle Function in Continent SubjectS

NCT03975686
View directory record Official record
Conditions
Pelvic Floor Muscle Weakness, Stress Urinary Incontinence, Pelvic Asymmetry
Interventions
neuromuscual realigning exercise
Other
Lead sponsor
University of North Georgia
Other
Eligibility
18 Years to 45 Years
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020
U.S. locations
1
States / cities
Dahlonega, Georgia
Source: ClinicalTrials.gov public record
Updated Mar 30, 2020 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional

Enhanced Consent and Preparedness for Surgery Trial

NCT03988569
View directory record Official record
Conditions
Stress Urinary Incontinence, Urge Incontinence, Pelvic Organ Prolapse
Interventions
audiovisual decision aid
Other
Lead sponsor
Loyola University
Other
Eligibility
18 Years and older · Female only
Enrollment
158 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2024
U.S. locations
1
States / cities
Maywood, Illinois
Source: ClinicalTrials.gov public record
Updated Mar 11, 2024 · Synced Sep 26, 2026, 3:03 AM EDT
Recruiting Not applicable Interventional

A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)

NCT06968741
View directory record Official record
Conditions
Stress Urinary Incontinence (SUI)
Interventions
Artificial Urinary Sphincter (AUS)
Device
Lead sponsor
UroMems SAS
Industry
Eligibility
22 Years and older · Male only
Enrollment
140 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2031
U.S. locations
13
States / cities
Los Angeles, California • San Francisco, California • Stanford, California + 9 more
Source: ClinicalTrials.gov public record
Updated Mar 26, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Not yet recruiting Phase 4 Interventional

Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

NCT07600697
View directory record Official record
Conditions
Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI), Postoperative Pain
Interventions
Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen
Drug
Lead sponsor
University of California, Los Angeles
Other
Eligibility
18 Years and older · Female only
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Sep 14, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence

NCT00734968
View directory record Official record
Conditions
Stress Incontinence
Interventions
Nitrofurantoin, Placebo
Drug · Other
Lead sponsor
University of Missouri-Columbia
Other
Eligibility
18 Years and older · Female only
Enrollment
161 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2010
U.S. locations
1
States / cities
Temple, Texas
Source: ClinicalTrials.gov public record
Updated Oct 10, 2016 · Synced Sep 26, 2026, 3:03 AM EDT
Completed No phase listed Observational

Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy

NCT01982188
View directory record Official record
Conditions
Stress Urinary Incontinence (SUI)
Interventions
Not listed
Lead sponsor
Atlantic Health System
Other
Eligibility
Female only
Enrollment
104 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2013
U.S. locations
1
States / cities
Morristown, New Jersey
Source: ClinicalTrials.gov public record
Updated Aug 10, 2016 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional

Identifying Stress Urinary Incontinence in Women With Pelvic Organ Prolapse

NCT03005977
View directory record Official record
Conditions
Stress Urinary Incontinence, Pelvic Organ Prolapse
Interventions
Urodynamics
Procedure
Lead sponsor
The Cleveland Clinic
Other
Eligibility
18 Years and older · Female only
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2021
U.S. locations
1
States / cities
Weston, Florida
Source: ClinicalTrials.gov public record
Updated Apr 6, 2022 · Synced Sep 26, 2026, 3:03 AM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Fat Grafting Technique Using Autologous Adipose Tissue Lipogems in Patients Suffering From Stress Urinary Incontinence

NCT03295253
View directory record Official record
Conditions
Urinary Incontinence,Stress
Interventions
Autologous adipose tissue harvesting/grafting using Lipogems
Procedure
Lead sponsor
The Miriam Hospital
Other
Eligibility
18 Years and older · Female only
Enrollment
25 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016 – 2018
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Sep 26, 2017 · Synced Sep 26, 2026, 3:03 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair

NCT02502838
View directory record Official record
Conditions
Overactive Bladder, Pelvic Organ Prolapse
Interventions
Not listed
Lead sponsor
Icahn School of Medicine at Mount Sinai
Other
Eligibility
22 Years and older · Female only
Enrollment
40 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015 – 2017
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Aug 31, 2017 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Phase 2 Interventional

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

NCT00190567
View directory record Official record
Conditions
Urinary Stress Incontinence
Interventions
duloxetine, Placebo
Drug
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years to 75 Years · Female only
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2001 – 2006
U.S. locations
1
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated Jan 25, 2007 · Synced Sep 26, 2026, 3:03 AM EDT
Recruiting Phase 4 Interventional

Prophylactic Antibiotics for Outpatient Urethral Bulking

NCT07501065
View directory record Official record
Conditions
Urinary Tract Infections, Stress Urinary Incontinence, Urinary Incontinence
Interventions
Bactrim (800/160 mg), Keflex (500 mg), Cipro (250 mg), or Macrobid (100mg)
Drug
Lead sponsor
University of Miami
Other
Eligibility
18 Years and older · Female only
Enrollment
150 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
2
States / cities
Miami, Florida
Source: ClinicalTrials.gov public record
Updated Aug 19, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Active, not recruiting No phase listed Observational

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

NCT04829994
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
Intervention
Device
Lead sponsor
Ethicon, Inc.
Industry
Eligibility
21 Years and older · Female only
Enrollment
198 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2035
U.S. locations
3
States / cities
Durham, North Carolina • North Wales, Pennsylvania • Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jul 5, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Active, not recruiting Not applicable Interventional

Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

NCT06862648
View directory record Official record
Conditions
Stress Urinary Incontinence (SUI)
Interventions
Acoustic Stimulation Therapy Device, Sham Acoustic Stimulation Therapy Device
Device
Lead sponsor
Acoustic Wave Cell Therapy, Inc.
Industry
Eligibility
22 Years to 77 Years · Female only
Enrollment
130 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
9
States / cities
Phoenix, Arizona • Lakeland, Florida • Boise, Idaho + 6 more
Source: ClinicalTrials.gov public record
Updated Apr 8, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Recruiting Not applicable Interventional

TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.

NCT06369922
View directory record Official record
Conditions
Stress Incontinence Female, Urinary Incontinence, Urinary Incontinence,Stress, Pain, Pain Acute
Interventions
TENS, Control TENS
Procedure
Lead sponsor
University of Rochester
Other
Eligibility
18 Years and older · Female only
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated May 12, 2026 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional

Solace Stress Urinary inContinence Control Efficacy and Safety Study

NCT02210273
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
Solace Bladder Control (Vesair) Balloon, Solace Sham Treatment
Device
Lead sponsor
Solace Therapeutics, Inc.
Industry
Eligibility
18 Years and older · Female only
Enrollment
221 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2019
U.S. locations
20
States / cities
Phoenix, Arizona • Tucson, Arizona • Denver, Colorado + 17 more
Source: ClinicalTrials.gov public record
Updated Jul 9, 2019 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional Results available

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence

NCT01290796
View directory record Official record
Conditions
Female Stress Urinary Incontinence
Interventions
Ajust Adjustable Single-Incision Sling
Device
Lead sponsor
C. R. Bard
Industry
Eligibility
18 Years and older · Female only
Enrollment
153 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2015
U.S. locations
6
States / cities
Newport Beach, California • Grand Rapids, Michigan • Princeton, New Jersey + 3 more
Source: ClinicalTrials.gov public record
Updated Mar 26, 2017 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Phase 3 Interventional

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

NCT00190632
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
Duloxetine
Drug
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years and older · Female only
Enrollment
600 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2001 – 2006
U.S. locations
1
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Jan 25, 2007 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

NCT02617472
View directory record Official record
Conditions
Stress Urinary Incontinence, Sexual Dysfunction
Interventions
Pelvic floor exerciser
Device
Lead sponsor
Lelo Inc.
Industry
Eligibility
20 Years to 69 Years · Female only
Enrollment
93 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2017
U.S. locations
1
States / cities
Phoenix, Arizona
Source: ClinicalTrials.gov public record
Updated Aug 13, 2017 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional Results available

TVT-SECUR as an Office-based Procedure

NCT01137539
View directory record Official record
Conditions
Urinary Incontinence, Stress Urinary Incontinence
Interventions
Gynecare TVT-SECUR system
Device
Lead sponsor
Michigan Institution of Women's Health PC
Other
Eligibility
21 Years to 89 Years · Female only
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2012
U.S. locations
1
States / cities
Dearborn, Michigan
Source: ClinicalTrials.gov public record
Updated Jun 27, 2017 · Synced Sep 26, 2026, 3:03 AM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Lyrette: Renewing Continence Objective and Subjective Efficacy Study

NCT01455779
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
Lyrette
Device
Lead sponsor
Verathon
Industry
Eligibility
35 Years to 60 Years · Female only
Enrollment
54 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2011 – 2015
U.S. locations
6
States / cities
Murrieta, California • Arlington Heights, Illinois • Oak Lawn, Illinois + 3 more
Source: ClinicalTrials.gov public record
Updated Dec 8, 2014 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Phase 2 Interventional

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

NCT00138749
View directory record Official record
Conditions
Urinary Incontinence, Stress
Interventions
SS-RBX
Drug
Lead sponsor
Pfizer
Industry
Eligibility
18 Years to 65 Years · Female only
Enrollment
402 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2006
U.S. locations
89
States / cities
Anchorage, Alaska • Sun City, Arizona • Tucson, Arizona + 78 more
Source: ClinicalTrials.gov public record
Updated Apr 6, 2011 · Synced Sep 26, 2026, 3:03 AM EDT
Completed Not applicable Interventional Results available

Impact of Decision Aids in Urogynecology

NCT04369404
View directory record Official record
Conditions
Pelvic Organ Prolapse, Stress Urinary Incontinence, Overactive Bladder
Interventions
Pelvic organ prolapse decision aid, Stress urinary incontinence decision aid, Overactive bladder decision aid
Behavioral
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
18 Years to 95 Years · Female only
Enrollment
66 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Apr 15, 2024 · Synced Sep 26, 2026, 3:03 AM EDT